{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:43:01Z","timestamp":1790286181630,"version":"4.1.0"},"reference-count":32,"publisher":"Japanese Circulation Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ Rep"],"published-print":{"date-parts":[[2025,10,10]]},"DOI":"10.1253\/circrep.cr-25-0115","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T22:07:41Z","timestamp":1756159661000},"page":"861-868","source":"Crossref","is-referenced-by-count":2,"title":["Ventricular Arrhythmia Risk Stratification Among Patients With Cardiac Resynchronization Therapy Devices"],"prefix":"10.1253","volume":"7","author":[{"given":"Nobuhiko","family":"Ueda","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Ishibashi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Noda","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"},{"name":"Cardiovascular Center, Kindai University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Oka","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Miyazaki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinori","family":"Wakamiya","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenzaburo","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukasa","family":"Kamakura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Wada","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Miyamoto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Nagase","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"},{"name":"Department of General Internal Medicine 3, Kawasaki Medical School General Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Aiba","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Kanzaki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chisato","family":"Izumi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruo","family":"Noguchi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Kusano","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. <i>N Engl J Med<\/i> 2002; 346: 8778\u20138783, doi:10.1056\/NEJMoa013474.","DOI":"10.1056\/NEJMoa013474"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Friedman DJ, Upadhyay GA, Rajabali A, Altman RK, Orencole M, Parks KA, et al. Progressive ventricular dysfunction among nonresponders to cardiac resynchronization therapy: Baseline predictors and associated clinical outcomes. <i>Heart Rhythm<\/i> 2014; 11: 1991\u20131998, doi:10.1016\/j.hrthm.2014.08.005.","DOI":"10.1016\/j.hrthm.2014.08.005"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Ruwald MH, Solomon SD, Foster E, Kutyifa V, Ruwald AC, Sherazi S, et al. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: Results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial. <i>Circulation<\/i> 2014; 130: 2278\u20132286, doi:10.1161\/CIRCULATIONAHA.114.011283.","DOI":"10.1161\/CIRCULATIONAHA.114.011283"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Sapp JL, Parkash R, Wells GA, Yetisir E, Gardner MJ, Healey JS, et al. Cardiac resynchronization therapy reduces ventricular arrhythmias in primary but not secondary prophylactic implantable cardioverter defibrillator patients: Insight from the resynchronization in ambulatory heart failure trial. <i>Circ Arrhythm Electrophysiol<\/i> 2017; 10: e004875, doi:10.1161\/CIRCEP.116.004875.","DOI":"10.1161\/CIRCEP.116.004875"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Nogami A, Kurita T, Abe H, Ando K, Ishikawa T, Imai K, et al. JCS\/JHRS 2019 guideline on non-pharmacotherapy of cardiac arrhythmias. <i>Circ J<\/i> 2021; 85: 1104\u20131244, doi:10.1253\/circj.CJ-20-0637.","DOI":"10.1253\/circj.CJ-20-0637"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Younis A, Goldberger JJ, Kutyifa V, Zareba W, Polonsky B, Klein H, et al. Predicted benefit of an implantable cardioverter-defibrillator: The MADIT-ICD benefit score. <i>Eur Heart J<\/i> 2021; 42: 1676\u20131684, doi:10.1093\/eurheartj\/ehaa1057.","DOI":"10.1093\/eurheartj\/ehaa1057"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Sato H, Noda T, Ito T, Yamamoto N, Chiba T, Hasebe Y, et al. Optimizing patient selection for cardiac resynchronization therapy with or without defibrillator in a multicenter study of Japanese patients: Assessment of the MADIT-ICD benefit score. <i>Circ J<\/i> 2025; 89: 224\u2013233, doi:10.1253\/circj.CJ-24-0329.","DOI":"10.1253\/circj.CJ-24-0329"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Surawicz B, Childers R, Deal BJ, Gettes LS, Bailey JJ, Gorgels A, et al. AHA\/ACCF\/HRS recommendations for the standardization and interpretation of the electrocardiogram: Part III: Intraventricular conduction disturbances: A scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: Endorsed by the International Society for Computerized Electrocardiology. <i>Circulation<\/i> 2009; 119: e235\u2013e240, doi:10.1161\/CIRCULATIONAHA.108.191095.","DOI":"10.1161\/CIRCULATIONAHA.108.191095"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. American Diabetes A. Diagnosis and classification of diabetes mellitus. <i>Diabetes Care<\/i> 2011; 34(Suppl 1): S62\u2013S69, doi:10.2337\/dc11-S062.","DOI":"10.2337\/dc11-S062"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Stevens PE, Levin A; Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: Synopsis of the kidney disease: Improving global outcomes 2012 clinical practice guideline. <i>Ann Intern Med<\/i> 2013; 158: 825\u2013830, doi:10.7326\/0003-4819-158-11-201306040-00007.","DOI":"10.7326\/0003-4819-158-11-201306040-00007"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Ypenburg C, van Bommel RJ, Borleffs CJ, Bleeker GB, Boersma E, Schalij MJ, et al. Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up. <i>J Am Coll Cardiol<\/i> 2009; 53: 483\u2013490, doi:10.1016\/j.jacc.2008.10.032.","DOI":"10.1016\/j.jacc.2008.10.032"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Wilcox JE, Fang JC, Margulies KB, Mann DL. Heart failure with recovered left ventricular ejection fraction: JACC Scientific Expert Panel. <i>J Am Coll Cardiol<\/i> 2020; 76: 719\u2013734, doi:10.1016\/j.jacc.2020.05.075.","DOI":"10.1016\/j.jacc.2020.05.075"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Adabag S, Patton KK, Buxton AE, Rector TS, Ensrud KE, Vakil K, et al. Association of implantable cardioverter defibrillators with survival in patients with and without improved ejection fraction: Secondary analysis of the sudden cardiac death in heart failure trial. <i>JAMA Cardiol<\/i> 2017; 2: 767\u2013774, doi:10.1001\/jamacardio.2017.1413.","DOI":"10.1001\/jamacardio.2017.1413"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. de Sousa MR, Morillo CA, Rabelo FT, Nogueira Filho AM, Ribeiro AL. Non-sustained ventricular tachycardia as a predictor of sudden cardiac death in patients with left ventricular dysfunction: A meta-analysis. <i>Eur J Heart Fail<\/i> 2008; 10: 1007\u20131014, doi:10.1016\/j.ejheart.2008.07.002.","DOI":"10.1016\/j.ejheart.2008.07.002"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Ehdaie A, Cingolani E, Shehata M, Wang X, Curtis AB, Chugh SS. Sex differences in cardiac arrhythmias: Clinical and research implications. <i>Circ Arrhythm Electrophysiol<\/i> 2018; 11: e005680, doi:10.1161\/CIRCEP.117.005680.","DOI":"10.1161\/CIRCEP.117.005680"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Vergara P, Solimene F, D\u2019Onofrio A, Pisano EC, Zanotto G, Pignalberi C, et al. Are atrial high-rate episodes associated with increased risk of ventricular arrhythmias and mortality? <i>JACC Clin Electrophysiol<\/i> 2019; 5: 1197\u20131208, doi:10.1016\/j.jacep.2019.06.018.","DOI":"10.1016\/j.jacep.2019.06.018"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Satake H, Fukuda K, Sakata Y, Miyata S, Nakano M, Kondo M, et al. Current status of primary prevention of sudden cardiac death with implantable cardioverter defibrillator in patients with chronic heart failure: A report from the CHART-2 Study. <i>Circ J<\/i> 2015; 79: 381\u2013390, doi:10.1253\/circj.CJ-14-0925.","DOI":"10.1253\/circj.CJ-14-0925"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Ueda N, Noda T, Kanaoka K, Miyazaki Y, Wakamiya A, Nakajima K, et al. Clinical significance of atrial tachyarrhythmia duration for ventricular arrhythmia in patients with cardiac resynchronization therapy. <i>Circ J<\/i> 2024; 88: 1138\u20131146, doi:10.1253\/circj.CJ-23-0547","DOI":"10.1253\/circj.CJ-23-0547"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Watanabe J, Shinozaki T, Shiba N, Fukahori K, Koseki Y, Karibe A, et al. Accumulation of risk markers predicts the incidence of sudden death in patients with chronic heart failure. <i>Eur J Heart Fail<\/i> 2006; 8: 237\u2013242, doi:10.1016\/j.ejheart.2005.08.003.","DOI":"10.1016\/j.ejheart.2005.08.003"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Goldenberg I, Vyas AK, Hall WJ, Moss AJ, Wang H, He H, et al. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. <i>J Am Coll Cardiol<\/i> 2008; 51: 288\u2013296, doi:10.1016\/j.jacc.2007.08.058.","DOI":"10.1016\/j.jacc.2007.08.058"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Tateishi R, Shimizu M, Suzuki M, Sakai E, Shimizu A, Shimada H, et al. Machine learning-based clustering using a 12-lead electrocardiogram in patients with a implantable cardioverter defibrillator to identify future ventricular arrhythmia. <i>Circ J<\/i> 2025; 89: 240\u2013250, doi:10.1253\/circj.CJ-24-0269.","DOI":"10.1253\/circj.CJ-24-0269"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Goldenberg I, Moss AJ, McNitt S, Zareba W, Hall WJ, Andrews ML, et al. Inverse relationship of blood pressure levels to sudden cardiac mortality and benefit of the implantable cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. <i>J Am Coll Cardiol<\/i> 2007; 49: 1427\u20131433, doi:10.1016\/j.jacc.2006.11.042.","DOI":"10.1016\/j.jacc.2006.11.042"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. Peterson PN, Greiner MA, Qualls LG, Al-Khatib SM, Curtis JP, Fonarow GC, et al. QRS duration, bundle-branch block morphology, and outcomes among older patients with heart failure receiving cardiac resynchronization therapy. <i>JAMA<\/i> 2013; 310: 617\u2013626, doi:10.1001\/jama.2013.8641.","DOI":"10.1001\/jama.2013.8641"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Goldenberg I, Moss AJ, Hall WJ, Foster E, Goldberger JJ, Santucci P, et al. Predictors of response to cardiac resynchronization therapy in the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT). <i>Circulation<\/i> 2011; 124: 1527\u20131536, doi:10.1161\/CIRCULATIONAHA.110.014324.","DOI":"10.1161\/CIRCULATIONAHA.110.014324"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Sipahi I, Chou JC, Hyden M, Rowland DY, Simon DI, Fang JC. Effect of QRS morphology on clinical event reduction with cardiac resynchronization therapy: Meta-analysis of randomized controlled trials. <i>Am Heart J<\/i> 2012; 163: 260\u2013267.e3, doi:10.1016\/j.ahj.2011.11.014.","DOI":"10.1016\/j.ahj.2011.11.014"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26. Kuperstein R, Goldenberg I, Moss AJ, Solomon S, Bourgoun M, Shah A, et al. Left atrial volume and the benefit of cardiac resynchronization therapy in the MADIT-CRT trial. <i>Circ Heart Fail<\/i> 2014; 7: 154\u2013160, doi:10.1161\/CIRCHEARTFAILURE.113.000748.","DOI":"10.1161\/CIRCHEARTFAILURE.113.000748"},{"key":"27","doi-asserted-by":"publisher","unstructured":"27. Matsukawa R, Kabu K, Koga E, Hara A, Kisanuki H, Sada M, et al. Optimizing guideline-directed medical therapy during hospitalization improves prognosis in patients with worsening heart failure requiring readmissions. <i>Circ J<\/i> 2024; 88: 1416\u20131424, doi:10.1253\/circj.CJ-24-0265.","DOI":"10.1253\/circj.CJ-24-0265"},{"key":"28","doi-asserted-by":"publisher","unstructured":"28. Imamura T, Nakai M, Iwanaga Y, Sumita Y, Tao M, Ohno Y, et al. Two-year clinical outcome of mitraclip transcatheter edge-to-edge repair from the J-MITRA registry data. <i>Circ J<\/i> 2024; 88: 539\u2013548, doi:10.1253\/circj.CJ-23-0924.","DOI":"10.1253\/circj.CJ-23-0924"},{"key":"29","doi-asserted-by":"publisher","unstructured":"29. Shiga T, Shiozaki M, Takahashi R, Matsumoto R, Fukui M. Post-marketing surveillance of the safety of landiolol in patients with recurrent hemodynamically unstable ventricular tachyarrhythmias. <i>Circ J<\/i> 2025; 89: 784\u2013792, doi:10.1253\/circj.CJ-24-0898.","DOI":"10.1253\/circj.CJ-24-0898"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. <i>N Engl J Med<\/i> 2009; 361: 1329\u20131338, doi:10.1056\/NEJMoa0906431.","DOI":"10.1056\/NEJMoa0906431"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. <i>N Engl J Med<\/i> 2004; 350: 2140\u20132150, doi:10.1056\/NEJMoa032423.","DOI":"10.1056\/NEJMoa032423"},{"key":"32","doi-asserted-by":"publisher","unstructured":"32. van Stipdonk AMW, Hoogland R, Ter Horst I, Kloosterman M, Vanbelle S, Crijns H, et al. Evaluating electrocardiography-based identification of cardiac resynchronization therapy responders beyond current left bundle branch block definitions. <i>JACC Clin Electrophysiol<\/i> 2020; 6: 193\u2013203, doi:10.1016\/j.jacep.2019.10.009.","DOI":"10.1016\/j.jacep.2019.10.009"}],"container-title":["Circulation Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circrep\/7\/10\/7_CR-25-0115\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T04:06:18Z","timestamp":1760155578000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circrep\/7\/10\/7_CR-25-0115\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,10]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1253\/circrep.cr-25-0115","relation":{},"ISSN":["2434-0790"],"issn-type":[{"value":"2434-0790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,10]]},"article-number":"CR-25-0115"}}